Condition
Actinic Keratosis (AK) clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Actinic Keratosis (AK) clinical trials that are recruiting, at sites in 5 countries (most in United States (3), Australia (1), Denmark (1)). By phase: Phase 1 (2), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 5Countries
Newest Actinic Keratosis (AK) clinical trials
All recruiting trials (7)
-
Multimodal Laser Treatment for Photodamaged Facial Skin
A randomized split-face study tests a combination of three lasers and light therapy to improve sun-damaged facial skin and potentially help prevent skin cancer in adults with actinic keratosis.
-
Pharmacokinetic test of reformulated Levulan Kerastick for actinic keratosis on forearms or face
This study tests how the reformulated Levulan Kerastick behaves in the body when used on actinic keratosis lesions on the arms or face, followed by blue-light treatment.
-
Tirbanibulin in adults with facial actinic keratosis: seeing if it improves appearance and skin feel
This study checks whether tirbanibulin used for facial actinic keratosis helps improve how the skin looks and feels over 57 days in adults already using the medicine.
-
Photoprotection with Anthelios Fluide 100 KA+ UVMune 400 for people with multiple actinic keratoses
This trial will see if daily use of the sunscreen Anthelios Fluide 100 KA+ UVMune 400 together with good sun-protection habits helps protect people aged 60 and older who have multiple actinic keratoses.
-
HW211026 ointment for facial actinic keratosis
This will test a new topical ointment, HW211026, on the face to see if it is safe and how the body absorbs and responds to it in people with actinic keratosis.
-
Topical 5% Niacinamide for Skin Cancer Prevention in Organ Transplant Recipients
This trial tests whether applying a 5% niacinamide cream daily, in addition to sunscreen, can reduce actinic keratoses and new skin cancers in adults who have had an organ transplant.
-
Topical tirbanibulin (Klisyri) for actinic keratoses with downward-directed growth
We will test whether applying topical tirbanibulin (Klisyri) can reduce downward-directed proliferation of actinic keratoses on the scalp or face in adults.
Related topics
Quick answers
How many Actinic Keratosis (AK) clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (3 trials), Australia (1 trial), Denmark (1 trial), China (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.